# Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children

> **NCT01000831** · PHASE4 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 167 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** adjuvanted Arepanrix

## Key facts

- **NCT ID:** NCT01000831
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 167 (ACTUAL)
- **Last updated:** 2015-04-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01000831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01000831, "Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01000831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*